Neptunus Biology Overview
- Year Founded
-
1992
- Status
-
Public
- Employees
-
6,734
- Stock Symbol
-
000078
- Investments
-
6
- Share Price
-
$0.19
- (As of Friday Closing)
Neptunus Biology General Information
Description
Shenzhen Neptunus Bioengineering Co Ltd is primarily engaged in the research and development, manufacture and distribution of pharmaceutical products in China.
Contact Information
Website
www.neptunusbio.comCorporate Office
- 24th Floor, Neptune Galaxy Technology Building
- No. 1 Kejizhong 3rd Road, Nanshan District
- Shenzhen, Guangdong 518057
- China
Corporate Office
- 24th Floor, Neptune Galaxy Technology Building
- No. 1 Kejizhong 3rd Road, Nanshan District
- Shenzhen, Guangdong 518057
- China
Neptunus Biology Stock Performance
As of 13-Nov-2026, Neptunus Biology’s stock price is $0.19. Its current market cap is $501M with 2.63B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.19 | $0.19 | $0.18 - $0.81 | $501M | 2.63B | 53.8M | -$0.05 |
Neptunus Biology Financials Summary
As of 30-Sep-2026, Neptunus Biology has a trailing 12-month revenue of $3.09B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,868,276 | 2,638,526 | 2,132,404 | 2,701,303 |
| Revenue | 3,094,011 | 3,708,319 | 4,225,135 | 5,147,617 |
| EBITDA | (73,570) | 41,316 | (10,044) | (39,210) |
| Net Income | (139,189) | (78,297) | (166,319) | (238,865) |
| Total Assets | 3,264,134 | 3,763,697 | 3,944,921 | 4,557,273 |
| Total Debt | 1,476,187 | 1,672,061 | 1,448,511 | 1,607,960 |
Neptunus Biology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Neptunus Biology Signals
Neptunus Biology Investments & Acquisitions (6)
Neptunus Biology’s most recent deal was a Merger/Acquisition with Dongsen Pharmaceutical. The deal was made on 02-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dongsen Pharmaceutical | 02-Jan-2025 | Merger/Acquisition | Distributors (Healthcare) | ||
| Dongsen Pharmaceutical | 29-Feb-2024 | Secondary Transaction - Private | Distributors (Healthcare) | ||
| Haiwang Huitong Medicine | 29-Feb-2024 | Secondary Transaction - Private | Medical Supplies | ||
| Julikang | 05-Apr-2017 | Later Stage VC | Other Healthcare Services | ||
| Anhui Medicine Industry | 24-Aug-2016 | Merger/Acquisition | Pharmaceuticals |
Neptunus Biology ESG
Risk Overview
Risk Rating
Updated December, 31, 2023
26.22 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Pharmaceuticals
Industry
of 891
Rank
Percentile
Biotechnology
Subindustry
of 394
Rank
Percentile
Neptunus Biology Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Dongsen Pharmaceutical | Nanyang, China | 2002 |
Neptunus Biology FAQs
-
When was Neptunus Biology founded?
Neptunus Biology was founded in 1992.
-
Where is Neptunus Biology headquartered?
Neptunus Biology is headquartered in Shenzhen, China.
-
What is the size of Neptunus Biology?
Neptunus Biology has 6,734 total employees.
-
What industry is Neptunus Biology in?
Neptunus Biology’s primary industry is Pharmaceuticals.
-
Is Neptunus Biology a private or public company?
Neptunus Biology is a Public company.
-
What is Neptunus Biology’s stock symbol?
The ticker symbol for Neptunus Biology is 000078.
-
What is the current stock price of Neptunus Biology?
As of 13-Nov-2026 the stock price of Neptunus Biology is $0.19.
-
What is the current market cap of Neptunus Biology?
The current market capitalization of Neptunus Biology is $501M.
-
What is Neptunus Biology’s current revenue?
The trailing twelve month revenue for Neptunus Biology is $3.09B.
-
What is Neptunus Biology’s annual earnings per share (EPS)?
Neptunus Biology’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process